SCHEMBL29525697

SCHEMBL29525697

O=C1CCCc2nc(O)cnc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.36
GRM5 P41594 5/20 0.33
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
KDM4E B2RXH2 3/20 0.33
KMT2A Q03164 2/20 0.33
MAOA P21397 2/20 0.33
MAOB P27338 2/20 0.33
TSHR P16473 1/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ELANE P08246 1/20 0.33
MAPK1 P28482 1/20 0.33
MAPT P10636 2/20 0.33
USP2 O75604 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22773696 1.00 HTT (0.36) HTTGRM5ALDH1A1SMN1; SMN2NPC1
SCHEMBL19152982 0.79 TSHR (0.40) HTTGRM5ALDH1A1SMN1; SMN2NPC1
SCHEMBL30646095 0.78 GRM5 (0.42) HTTGRM5ALDH1A1SMN1; SMN2NPC1
SCHEMBL18238059 0.74 TSHR (0.34) HTTGRM5ALDH1A1SMN1; SMN2NPC1
SCHEMBL9014728 0.71 NPC1 (0.37) ALDH1A1NPC1RAB9AKDM4EKMT2A
SCHEMBL29649268 0.70 HTT (0.41) HTTGRM5ALDH1A1SMN1; SMN2NPC1
SCHEMBL1988087 0.70 HTT (0.41) HTTGRM5ALDH1A1SMN1; SMN2NPC1
SCHEMBL22787128 0.69 LTB4R (0.38) SMN1; SMN2KDM4EKMT2ATSHRMEN1
SCHEMBL29526263 0.68 GRM5 (0.51) GRM5ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL17361975 0.68 GRM5 (0.51) GRM5ALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983406-A1 UNSATURATED HETEROCYCLOALKYL AND HETEROAROMATIC ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF Ontario Institute for Cancer Research (OICR) (CA) 2022-04-20 EP disclosed